NVP-ADW742 is primarily utilized in research settings to study its effects on cancer cell growth and proliferation. It functions as an inhibitor of the insulin-like growth factor 1 receptor (IGF-1R), which plays a critical role in the development and progression of various cancers. By blocking this receptor, it helps researchers understand the mechanisms of tumor growth and explore potential therapeutic strategies. This compound is particularly valuable in preclinical studies focused on cancers where IGF-1R signaling is implicated, such as breast, prostate, and lung cancers. Additionally, studies suggest that it may enhance the efficacy of other chemotherapeutic agents when used in combination, making it interesting for developing targeted cancer therapies. Its application aids in identifying pathways that could be targeted for the development of new anticancer drugs.